Anika Therapeutics (ANIK) Tops Q2 EPS by 10c, Beats on Revenue; Offers FY24 Revenue Guidance
Go back to Anika Therapeutics (ANIK) Tops Q2 EPS by 10c, Beats on Revenue; Offers FY24 Revenue Guidance| Anika Therapeutics, Inc. (NASDAQ: ANIK) | Delayed: 14.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.20 | 52 Week High | $54.96 | |||
| Open | $14.20 | 52 Week Low | $35.07 | |||
| Day High | $14.20 | P/E | 11.27 | |||
| Day Low | $14.20 | EPS | $1.26 | |||
| Volume | 3 | |||||
